← Return to Anyone taken Evenity (romosozumab) for Osteoporosis?
DiscussionAnyone taken Evenity (romosozumab) for Osteoporosis?
Osteoporosis & Bone Health | Last Active: 4 days ago | Replies (1363)Comment receiving replies
Replies to "Evenity can be continued for two years and will continue to benefit bone density according to..."
I reviewed the study about continuing Evenity for two years with my endocrinologist. The study is posted here: https://pubmed.ncbi.nlm.nih.gov/29694685/ My endocrinologist wrote me an email that says the following: "Based on the current knowledge I would not favor proceeding directly with a second year of Evenity, but rather switch to an anti-resorbing drug. Having said that, a second Evenity course in the future is a reasonable option. Another alternative is to switch to a cyclical form of therapy, with intervening short courses of Evenity against a background therapy with anti-resorbing agents."
I would appreciate thoughts of anyone who has experience related to this.
Thanks for the post. Interesting that the trial results were published in 2018 and today's general recommendation is for a year of treatment as it seems to lose efficacy after that amount of time. Likely the insurance companies will not cover beyond a year. I plan to begin Evenity soon but am concerned about follow-up treatment such as Prolia.